←Back to Expert Scholars
Translational Medicine / 转化医学Hodgkin Lymphoma
Andreas Engert
MD
🏢University Hospital Cologne🌐Germany
Professor of Internal Medicine, Hematology and Oncology
110
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Andreas Engert chairs the German Hodgkin Study Group and has led decades of practice-changing trials including BEACOPP, HD18, and PET-adapted de-escalation strategies. His work has transformed the treatment of advanced and early-stage Hodgkin lymphoma.
Share:
🧪Research Fields 研究领域
German Hodgkin Study Group
BEACOPP
PET-adapted therapy
de-escalation
Hodgkin lymphoma trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Andreas Engert 的研究动态
Follow Andreas Engert's research updates
留下邮箱，当我们发布与 Andreas Engert（University Hospital Cologne）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment